Lepu Biopharma Plans New Supervisor Appointment and Registered Address Change

Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ) has issued an announcement.

Lepu Biopharma has proposed appointing long-time Lepu Medical executive Fan Xinyu as a supervisor, filling the vacancy created by the retirement of Yang Ming, with her term to run until the end of the current supervisory session pending shareholder approval. Fan, who brings extensive experience in public relations, marketing, sales and human resources, will receive annual remuneration of RMB150,000 and has no disclosed related-party ties or market interests under Hong Kong listing rules.

The company also plans to change its registered address within Shanghai from Su Zhao Road to a new site on Lianheng Road in Minhang District, subject to regulatory approval by industrial and commercial authorities. To reflect this relocation, Lepu Biopharma will amend its Articles of Association to update the corporate address, while leaving all other provisions unchanged, signalling an administrative but operationally meaningful adjustment to its corporate registration base.

More about Lepu Biopharma Co. Ltd. Class H

Lepu Biopharma Co., Ltd. is a China-based biopharmaceutical company focused on the research, development and commercialization of innovative oncology therapies. Listed in Hong Kong under stock code 2157, the company operates primarily from Shanghai, serving domestic and potentially broader regional healthcare markets.

Average Trading Volume: 12,057,290

Technical Sentiment Signal: Hold

Current Market Cap: HK$10.16B

Find detailed analytics on 2157 stock on TipRanks’ Stock Analysis page.